Today: 30 June 2026
XRP price today: Ripple token bounces as DTCC listing and Iran war headlines steer crypto traders
9 June 2026
2 mins read

XRP Price Holds $1.10 as Key Level for Traders

London, June 9, 2026, 19:43 (BST)

XRP dropped Tuesday, last changing hands at $1.14, off about 2.6%. Crypto prices tried to bounce but faded. Bitcoin dipped to near $61,683, while ether was around $1,650. Larger tokens stayed soft, weighing on XRP.

XRP is trading near $1.10, a level where buyers stepped in after last week’s drop to four-month lows. More than 25 million XRP left exchanges, CoinDesk said Monday, and XRP-linked exchange-traded funds brought in about $118 million in May. Traders are eyeing $1.13-$1.14 as support, with resistance at $1.15-$1.20. Support is where buyers have recently come in. Resistance is where sellers have slowed advances.

The token sits in a tight spot. There are some signs of accumulation below, but price action hasn’t shifted enough to signal a turn.

Bitcoin fell 3.8% over 24 hours, according to CoinDesk’s live market coverage earlier in U.S. trading. Ether, solana and XRP dropped about 2.5% each, while U.S. stocks lost steam. For XRP, it wasn’t a Ripple-driven move—just part of a wider pullback from risk.

Capital flow is another issue here. Bernstein pointed out that bitcoin ETF flows slowed in 2026 as retail money went after AI-themed assets. ETF outflows hit about $2.6 billion this year. “Bitcoin still may offer some diversification from the unusual singular AI driven momentum markets we have experienced this year,” Bernstein analysts led by Gautam Chhugani wrote, according to CoinDesk. CoinDesk

XRP isn’t at the heart of this, but it’s relevant. With less new cash coming into bitcoin—the most liquid crypto—other large cap tokens like XRP can have a tougher time finding buyers.

Lekker Capital CIO Quinn Thompson was bearish on crypto, saying bitcoin is still weighed down by digital-asset treasury worries, Strategy’s preferred shares, and quantum-computing risks. Thompson also told CoinDesk that upcoming IPOs like SpaceX, Anthropic, and OpenAI are fighting for both capital and attention.

Regulation didn’t take center stage. Stand With Crypto, the Blockchain Association, the Crypto Council for Innovation, and The Digital Chamber sent a letter on June 7 pressing Senate leaders to bring the Clarity Act to a Senate vote. Ripple was one of the signers. The measure would create a federal system for digital-asset markets and registration options, which could benefit tokens like XRP in the long run. It isn’t aimed at today’s selling pressures.

The bounce from $1.09 could have been short-lived. BlackRock Investment Institute said it is watching the U.S. Consumer Price Index on Wednesday for clues if the Middle East energy shock is pushing up already stubborn inflation. Higher inflation would make it harder for rates to fall, and that puts pressure on speculative assets like crypto.

Bitcoin is still leading the downside, traders said. “If the mid-$50Ks fail to hold, the next backstop is the $48K-$52K range,” Jean-David Péquignot, chief commercial officer at Deribit, said to CoinDesk on Monday. A move below that could drag XRP into the same risk-off trade. CoinDesk

XRP is still holding up, though buyers don’t have confirmation. Bulls need a move over $1.20 to start making their case. If XRP dips below $1.10 again, the week’s low stops looking like a flush and more like there’s more to come.

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story
Previous Story

Paranovus Stock Rockets 620% as $195 Million Share-Sale Filing Changes the Story

Colorado PERA pay dispute spotlights mix of big bonuses and lower pensions
Next Story

Colorado PERA pay dispute spotlights mix of big bonuses and lower pensions

Go toTop